Brain

Annals of Family Medicine: Four New Studies Test Digital and Artificial Intelligence Screening Tools in Family Medicine

New research inĀ Annals of Family Medicine explores the use of artificial intelligence, apps, and tablets to detect dementia, heart dysfunction,…

10 months ago

MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety

Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at…

10 months ago

MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety

Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at…

10 months ago

MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety

Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at…

10 months ago

LEVEL EX LAUNCHES LEVEL ONE, A FREE MOBILE GAME TO REDEFINE TYPE 1 DIABETES ONBOARDING

Now available on iOS and Android, Level One helps newly diagnosed Type 1 Diabetics and their caregivers master insulin management…

10 months ago

LEVEL EX LAUNCHES LEVEL ONE, A FREE MOBILE GAME TO REDEFINE TYPE 1 DIABETES ONBOARDING

Now available on iOS and Android, Level One helps newly diagnosed Type 1 Diabetics and their caregivers master insulin management…

10 months ago

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025…

10 months ago

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025…

10 months ago

Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases

- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological…

10 months ago

Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases

- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological…

10 months ago